Anabolic Resistance May Be The Reason Befind Why Eating Enough Protein Isn’t Always Enough to Rebuild MuscleWhat new research on muscle aging reveals about anabolic resistance, mitochondrial function, and why recovery requires more than the right nutrients.

You may be eating enough protein. You may be taking supplements, exercising, and doing everything you have been told should help preserve your muscles.

Yet your strength has not returned. You tire more easily, everyday tasks require greater effort, or your body struggles to recover after activity.

Why?

Because having the materials needed to build muscle is not the same as having the biological capacity to use them effectively.

A 2025 scientific review on sarcopenia—the age-related loss of muscle strength and function—helps explain why.

The researchers examined how aging, inflammation, mitochondrial dysfunction, nutrition, and changes in the nervous system interact to affect muscle health, including anabolic resistance.

Their findings offer an important lesson: restoring muscle function involves more than simply supplying protein. It also depends on how muscle responds to nutrients, how well it produces and manages energy, how effectively nerves activate it, and whether the body can adapt to physical demands.

This distinction is particularly relevant to understanding why recovery sometimes stalls.

What Is Sarcopenia?

Sarcopenia is a muscle disorder involving reduced muscle strength and, often, loss of muscle quantity or quality.

It becomes more common with age, but aging is not its only cause.

Inactivity, inadequate nutrition, chronic illness, inflammation, and neurological problems may also contribute.

Sarcopenia can affect much more than appearance or muscle size. It may make it harder to climb stairs, rise from a chair, carry groceries, maintain balance, or remain independent.

One important distinction is often overlooked:

Muscle mass and muscle strength are not the same thing.

A person can have a reasonable amount of muscle but still be weak because the muscle is not working effectively.

Likewise, someone may improve their strength without gaining a large amount of muscle.

That is why muscle health must be evaluated through function, not appearance or body composition alone.

Why Protein Alone May Not Restore Muscle

Protein provides amino acids, which the body uses to maintain and build muscle proteins.

When we consume protein, amino acids can stimulate muscle protein synthesis. Resistance exercise provides another important signal telling muscle tissue to adapt.

But the body’s response to these signals may change with age or illness.

What Is Anabolic Resistance?

Anabolic resistance means the muscles respond less effectively to normally muscle-building signals, including amino acids and resistance exercise.

An older adult may therefore experience less muscle protein synthesis from a given meal or exercise stimulus than a younger, healthy individual.

Several conditions can contribute to anabolic resistance, including prolonged inactivity, metabolic disease, inflammatory stress, and altered muscle signaling.

This does not mean protein is unimportant. It means that protein is one requirement within a larger process.

Think of building a house.

You need wood, concrete, and other materials. But delivering those materials does not guarantee that the workers, equipment, and building process can function properly.

Muscle recovery operates on a similar principle.

Protein supplies materials. The body’s regulatory and repair systems determine how effectively those materials can be used.

Mitochondria: The Energy Side of Muscle Recovery

Muscles require energy to contract, recover, and adapt.

Much of that energy is produced by mitochondria, the small structures inside cells involved in energy metabolism.

The sarcopenia review describes how aging can be associated with changes in mitochondrial function, increased oxidative stress, and reduced mitochondrial quality control.

Mitochondria must do more than produce energy. Cells also need to maintain healthy mitochondria and remove damaged ones through processes such as mitophagy.

If these maintenance systems become less effective, muscle function may suffer.

However, an important scientific qualification is necessary.

This does not mean every older person with muscle weakness has mitochondrial dysfunction.

Weakness has many possible causes, including neurological disease, medication effects, inadequate nutrition, and inactivity.

The review identifies mitochondrial dysfunction as one potential contributor, not a universal explanation.

Inflammation Can Affect Muscle Maintenance

Inflammation is part of normal immune defense and tissue repair.

However, persistent inflammatory activity may interfere with muscle maintenance.

The review discusses how inflammatory signals can influence pathways involved in muscle protein breakdown, cellular stress, and mitochondrial function.

In some circumstances, the body may break down muscle proteins faster than it can replace them.

This can become especially important during chronic illness, prolonged inactivity, or poor nutritional intake.

But inflammation is not always harmful. Exercise itself produces temporary biological signals that help the body adapt.

The difference lies partly in the context, intensity, and duration of those signals.

A temporary response to appropriate exercise is not the same as ongoing inflammatory stress associated with disease.

Your Nervous System Also Determines Muscle Strength

Muscles do not work independently of the nervous system.

Nerves activate muscle fibers, coordinate movement, and help regulate the force required for different tasks.

With aging, changes can occur in motor neurons, motor units, and the connections between nerves and muscles.

These changes may reduce how effectively muscle fibers are recruited.

This means muscle weakness cannot always be corrected simply by increasing protein intake or stimulating muscle growth.

Some people may need interventions directed toward balance, coordination, neurological function, or carefully structured rehabilitation.

The important lesson is that usable muscle function depends on both healthy tissue and effective nervous-system control.

The Gut–Muscle–Brain Connection

The review also explores an emerging area of research: communication among the gastrointestinal system, skeletal muscle, and brain.

The gut contributes to muscle health in several established ways.

It helps digest and absorb protein, energy, vitamins, and minerals. Gastrointestinal symptoms or restrictive diets may reduce how much nutrition a person can comfortably consume.

Researchers are also investigating whether microbial metabolites and gut-associated immune signals influence muscle metabolism and neurological health.

For example, short-chain fatty acids produced by intestinal bacteria may participate in broader metabolic and immune signaling.

However, much of the evidence connecting specific microbial patterns to sarcopenia remains preliminary.

The presence or absence of certain organisms in a stool test does not establish why someone is losing muscle.

For patients with chronic digestive symptoms, the immediate priority may be ensuring enough food can be eaten, digested, absorbed, and tolerated.

That is a practical concern supported by established nutritional physiology—not a reason to assume every case of muscle loss begins in the microbiome.

Why This Research Matters to Healing in Order

One of the central principles of the Ettinger Foundation Protocol is:

Capacity requires substrate.

The body needs enough protein, energy, and other essential nutrients to support its normal functions.

But this research helps clarify a second part of the equation:

Having enough substrate does not guarantee that the body can respond to it effectively.

Within the Healing in Order framework, several physiological questions matter.

Phase 4 — Is There Sustainable Metabolic Capacity?

Can the person support ordinary physical activity without disproportionate fatigue or prolonged recovery?

Mitochondrial function and energy metabolism contribute to muscle activity, but they cannot be assessed from fatigue alone.

Phase 5 — Can the Body Respond to Repair and Loading?

Once appropriate stability and tolerance are present, progressively challenging the muscles can stimulate adaptation.

This requires nutritional resources, functioning neuromuscular pathways, appropriate loading, and recovery.

More stimulation is not automatically better.

Phase 6 — Can Improved Function Be Maintained?

The goal is not simply one stronger workout or a better body-composition measurement.

It is sustainable strength, mobility, and physical function over time.

In EFP, recovery and repeatability are especially important indicators of how well a person is tolerating increasing demands.

These are applications of the EFP clinical model. The sarcopenia review did not test or validate the EFP phase sequence.

What This Changes—and What It Doesn’t

The review reinforces established evidence supporting resistance training and adequate nutrition for muscle health.

It also highlights emerging mechanisms involving inflammation, mitochondrial quality control, anabolic resistance, and neuromuscular function.

But the research does not show that everyone must first correct inflammation or mitochondrial function before performing resistance exercise.

Nor does it establish a particular supplement, peptide, probiotic, or mitochondrial treatment as necessary for muscle recovery.

For people who can safely exercise, progressive resistance training remains an important evidence-supported intervention.

For people with severe illness, autonomic instability, significant mobility limitations, or post-exertional symptom worsening, the approach may need to be modified and supervised.

Necessary nutritional care, sarcopenia evaluation, and appropriate rehabilitation should not be delayed simply because someone has not completed a particular EFP phase.

Five Clinical Lessons Worth Remembering

  1. Protein is essential, but protein adequacy does not guarantee muscle growth. The muscle’s response also matters.
  2. Muscle size is not the same as strength. Nerve function and muscle quality contribute to force production.
  3. Mitochondrial health matters, but fatigue does not diagnose mitochondrial dysfunction.
  4. Appropriate exercise is important, but loading must match the person’s current tolerance and medical condition.
  5. Recovery matters. Meaningful improvement should lead to usable function that can be maintained and repeated.

What Can You Do Now?

If you are concerned about declining muscle strength, begin with an appropriate clinical assessment rather than assuming that more supplements are the solution.

A clinician may evaluate nutritional intake, weight and muscle changes, medications, underlying illness, and functional measures such as grip strength, repeated chair rises, or walking performance.

Nutrition and resistance exercise are often central to the management of sarcopenia, but the approach should match the person’s abilities, health conditions, and safety needs.

If activity repeatedly leads to substantial worsening or delayed symptom flares, the exercise plan needs individual assessment rather than automatic escalation.

The goal is to find a sustainable path toward better function.

Final Perspective

Muscle recovery is not simply a matter of eating more protein or exercising harder.

It requires enough nutritional resources, a muscle system capable of responding, functioning neural connections, and an appropriate relationship between physical demand and recovery.

The scientific evidence supporting these biological components is substantial, although the precise sequence and importance of each factor vary among individuals.

The central principle of Healing in Order is that treatment should consider what the body can currently support.

The goal is not merely to build more muscle. It is to restore and maintain the capacity to use that muscle effectively.

Research Sources

Araújo LP, Godoy ACF, Frota FF, et al. Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches. International Journal of Molecular Sciences. 2025;26(24):12147.

Read the sarcopenia review

Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age and Ageing. 2019;48(1):16–31.

Read the sarcopenia diagnostic consensus